- Bayer is working closely with Health Canada and its Canadian
retail partners to ensure that all consumers are notified
immediately.
- Lots containing the following codes are
impacted: G238402 and G239889.
MISSISSAUGA, ON, April 18,
2024 /CNW/ - Bayer is recalling two lots of
hydraSense® Baby Nasal Care Easydose® due to a potential
contamination.
Lots containing the following codes are impacted: G238402
and G239889.
No other hydraSense® products are impacted.
The safety of Canadians and the quality of our products remains
our highest priority. We are working closely with Health Canada and
our Canadian retail partners to ensure that all consumers are
notified immediately, and that all impacted inventory is removed
from shelves and quarantined as soon as possible.
What should consumers do?
While no adverse events have
been reported at this time, consumers who believe that their
hydraSense® Baby Nasal Care Easydose® product is from an affected
lot are to stop using it immediately and to return it for a full
refund by completing a form at
www.hydrasense.ca/en/easydoserecall or by calling
1-800-265-7382.
If you have a medical concern, please speak with your health
care provider.
How to identify if your product is part of the
recall?
Lot numbers for hydraSense® Baby Nasal Care
Easydose® can be found on the bottom of the box containing the
single use vials and on the label of each single use vial.
For more information:
To report an adverse event,
product complaint or have questions about this recall, please
contact Bayer at 1-800-265-7382.
About Bayer
Bayer is a global enterprise with core
competencies in the life science fields of health care and
nutrition. In line with its mission, "Health for all, Hunger for
none," the company's products and services are designed to help
people and the planet thrive by supporting efforts to master the
major challenges presented by a growing and aging global
population. Bayer is committed to driving sustainable development
and generating a positive impact with its businesses. At the same
time, the Group aims to increase its earning power and create value
through innovation and growth. The Bayer brand stands for trust,
reliability, and quality throughout the world. In fiscal 2023, the
Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before
special items amounted to 5.8 billion
euros. For more information, go to www.bayer.ca
Find more information at www.bayer.ca
xx
(2024-0XXXE)
Forward-Looking Statements
This release may contain forward-looking statements based on
current assumptions and forecasts made by Bayer management. Various
known and unknown risks, uncertainties and other factors could lead
to material differences between the actual future results,
financial situation, development or performance of the company and
the estimates given here. These factors include those discussed in
Bayer's public reports which are available on the Bayer website at
www.bayer.com. The company assumes no liability whatsoever to
update these forward-looking statements or to conform them to
future events or developments.
SOURCE Bayer Inc.